Track top-performing Indian stocks for April 21, 2025. Get key updates on earnings, market trends, and expert picks to guide your investment decisions.


📈 Stocks to Watch

🏦 HDFC Bank & ICICI Bank

Both banks reported better-than-expected quarterly earnings, propelling their stock prices to record highs last week. Their robust performance contributed to Indian indices achieving their best weekly performance in over four years .​

💻 Infosys

Infosys missed revenue expectations and provided a cautious fiscal 2026 forecast due to global economic uncertainties and reduced client spending .​

🏦 Yes Bank

The bank surpassed quarterly earnings estimates, benefiting from lower loan-loss provisions .​

🏥 HDFC Life Insurance

Reported profit growth driven by increased demand for group insurance products .​

🏗️ Larsen & Toubro (L&T)

L&T's stock rose by 4.31% following a 14% increase in consolidated profit, attributed to higher revenue .

🏦 IndusInd Bank

Appointed Santosh Kumar as deputy CFO amidst regulatory scrutiny for accounting lapses .​


🌍 Market Outlook

Despite global uncertainties, including concerns over tariffs and U.S. economic policies, Indian markets have shown resilience. Foreign portfolio investors have been net buyers in recent sessions, supported by a weakening U.S. dollar and expectations of better growth prospects in India 

The Indian rupee is expected to trade positively, buoyed by solid foreign portfolio inflows and a weak U.S. dollar. Analysts anticipate the USD/INR pair to move between 85 and 85.80 in the near term

 

 

Source: Taken from multiple websites

Disclaimer
The information provided in this media release is based on current facts and circumstances as of the date of publication. It may contain forward-looking statements, including but not limited to projections, expectations, or assumptions about future events or performance. These forward-looking statements are subject to risks, uncertainties, and other factors that may cause actual results to differ materially from those anticipated. Hester Biosciences Ltd does not undertake any obligation to update, revise, or correct any forward-looking statements based on new information or future events. This release is intended for informational purposes only and does not constitute financial, investment, or professional advice.

Visitors : HTML Hit Counters